Research graph
References from Amphotericin B preparations: a maximum tolerated dose in severe invasive fungal infections?. Local targets link to admitted publications; unresolved targets remain external evidence.
The discovery and development of amphotericin B.
1968 · External reference
10.7326/0003-4819-124-10-199605150-00011
10.7326/0003-4819-124-10-199605150-00011 · External reference
10.1093/clinids/12.2.308
10.1093/clinids/12.2.308 · External reference
10.1093/infdis/152.5.1037
10.1093/infdis/152.5.1037 · External reference
10.1016/0002-9343(68)90075-2
10.1016/0002-9343(68)90075-2 · External reference
Favorable outcome of invasive aspergillosis in patients with acute leukemia.
10.1200/jco.1987.5.12.1985 · 1987 · External reference
Changes in the natural history of invasive pulmonary aspergillosis in neutropenic leukemic patients.
1996 · External reference
10.1093/clinids/12.6.1147
10.1093/clinids/12.6.1147 · External reference
Unresolved reference
1987 · External reference
10.1093/infdis/158.2.415
10.1093/infdis/158.2.415 · External reference
10.1093/infdis/151.5.902
10.1093/infdis/151.5.902 · External reference
10.1007/978-1-4899-3505-2_19
10.1007/978-1-4899-3505-2_19 · External reference
10.1159/000238524
10.1159/000238524 · External reference
10.1159/000238138
10.1159/000238138 · External reference
Experimental murine aspergillosis. Comparison of amphotericin B and a new polyene antifungal drug SCH28191.
1984 · External reference
10.1128/aac.29.4.602
10.1128/aac.29.4.602 · External reference
Accumulation of amphotericin B in human macrophages enhances activity against Aspergillus fumigatus conidia: quantification of conidial kill at the single cell level.
10.1128/aac.42.10.2569 · 1988 · External reference
10.1093/clinids/20.4.755
10.1093/clinids/20.4.755 · External reference
10.1128/aac.36.1.172
10.1128/aac.36.1.172 · External reference
Efficacy of low dose dopamine in preventing amphotericin B nephrotoxicity in bone marrow transplant patients and leukemia patients.
10.1128/aac.42.12.3103 · 1988 · External reference
10.1016/s0145-2126(96)00075-6
10.1016/s0145-2126(96)00075-6 · External reference
Liposomal and lipid based formulations of amphotericin B.
1996 · External reference
10.2165/00003088-199223040-00004
10.2165/00003088-199223040-00004 · External reference
10.1086/514672
10.1086/514672 · External reference
10.1007/bf01575124
10.1007/bf01575124 · External reference
Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis.
1997 · External reference
10.1038/sj.bmt.1700664
10.1038/sj.bmt.1700664 · External reference
10.1038/sj.bmt.1700842
10.1038/sj.bmt.1700842 · External reference
10.1038/sj.bmt.1701406
10.1038/sj.bmt.1701406 · External reference
Unresolved reference
External reference
10.1093/clinids/22.2.315
10.1093/clinids/22.2.315 · External reference
10.1016/s0140-6736(94)90663-7
10.1016/s0140-6736(94)90663-7 · External reference
Safety, tolerance and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (Ambisome) in neutropenic patients.
10.1128/aac.42.9.2391 · 1998 · External reference
10.1111/j.1365-2141.1994.tb04825.x
10.1111/j.1365-2141.1994.tb04825.x · External reference
10.1001/archinte.155.10.1093
10.1001/archinte.155.10.1093 · External reference
10.1086/516353
10.1086/516353 · External reference
10.1093/clinids/21.5.1145
10.1093/clinids/21.5.1145 · External reference
10.1046/j.1365-2141.1997.2473063.x
10.1046/j.1365-2141.1997.2473063.x · External reference
10.1056/nejm199903113401004
10.1056/nejm199903113401004 · External reference
10.1046/j.1365-2141.1998.00944.x
10.1046/j.1365-2141.1998.00944.x · External reference
10.1128/aac.41.6.1275
10.1128/aac.41.6.1275 · External reference
10.1093/jac/38.2.215
10.1093/jac/38.2.215 · External reference
10.1128/aac.38.3.518
10.1128/aac.38.3.518 · External reference
10.1093/infdis/169.2.356
10.1093/infdis/169.2.356 · External reference
10.1128/aac.38.11.2660
10.1128/aac.38.11.2660 · External reference
10.1093/jac/28.suppl_b.73
10.1093/jac/28.suppl_b.73 · External reference
10.1093/infdis/173.5.1208
10.1093/infdis/173.5.1208 · External reference
Liposomal amphotericin B (Ambisome) treatment in solid organ and bone marrow transplant recipients. Efficacy and safety evaluation.
10.1111/j.1399-0012.1990.tb00047.x · 1990 · External reference
10.1111/j.1439-0507.1993.tb00748.x
10.1111/j.1439-0507.1993.tb00748.x · External reference
10.1086/515033
10.1086/515033 · External reference
Lipid formulations of amphotericin B: clinical efficacy and toxicities.
10.1086/514704 · 1998 · External reference
10.1128/aac.39.9.1954
10.1128/aac.39.9.1954 · External reference
10.1093/jac/30.3.313
10.1093/jac/30.3.313 · External reference
10.1086/516360
10.1086/516360 · External reference
Th1 and Th2 cytokines in mice with invasive aspergillosis.
10.1128/iai.65.2.564-570.1997 · 1997 · External reference
Unresolved reference
External reference
Long circulating immunoliposomal amphotericin B against invasive pulmonary aspergillosis in mice.
10.1128/aac.42.1.40 · 1998 · External reference
